Lung Cancer And Normal Tissue Array, Non-overlapping With LUC481, 16 Cases/48 Cores|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173471

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Lung Cancer And Normal Tissue Array, Non-overlapping With LUC481, 16 Cases/48 Cores)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年06月06日 00時01分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Human Lung cancer and normal tissue array, non-overlapping with LUC481, 16cases/48cores
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年06月06日 00時01分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Human Lung cancer and normal tissue array, non-overlapping with LUC481, 16cases/48cores

文献数: 0

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Lung cancer tissue microarray, including 16 cases of carcinoma in duplicates and matched adjacent normal tissue as control
Cores: 48
Cases: 16
Layout: 8 cols × 6 rows
Core Diameter: 2 mm
Thickness: 4 µm
Quality Control: H&E, IHC anti-Cytokeratin
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 M 64 Lung Adenocarcinoma I T2N0M0 Malignant
A2 2 M 77 Lung Adenocarcinoma II T2N0M0 Malignant
A3 3 F 52 Lung Adenosquamous carcinoma III T2N1M0 Malignant
A4 4 M 49 Lung Small cell lung carcinoma III T2N0M0 Malignant
A5 5 M 73 Lung Adenocarcinoma III T2N0M0 Malignant
A6 6 F 58 Lung Bronchioloalveolar carcinoma T2N0M0 Malignant
A7 7 M 56 Lung Papillary adenocarcinomaa T3N0M0 Malignant
A8 8 F 48 Lung Papillary adenocarcinomaa T4N1M0 Malignant
B1 9 M 64 Lung Adenocarcinoma I T2N0M0 Malignant
B2 10 M 77 Lung Adenocarcinoma II T2N0M0 Malignant
B3 11 F 52 Lung Adenosquamous carcinoma III T2N1M0 Malignant
B4 12 M 49 Lung Small cell lung carcinoma III T2N0M0 Malignant
B5 13 M 73 Lung Adenocarcinoma III T2N0M0 Malignant
B6 14 F 58 Lung Bronchioloalveolar carcinoma T2N0M0 Malignant
B7 15 M 56 Lung Papillary adenocarcinomaa T3N0M0 Malignant
B8 16 F 48 Lung Papillary adenocarcinomaa T4N1M0 Malignant
C1 17 M 64 Lung Uninvolved lung tissue of A1,B1 Normal
C2 18 M 77 Lung Uninvolved lung tissue of A2,B2 Normal
C3 19 F 52 Lung Uninvolved lung tissue of A3,B3 Normal
C4 20 M 49 Lung Uninvolved lung tissue of A4,B4 Normal
C5 21 M 73 Lung Uninvolved lung tissue of A5,B5 Normal
C6 22 F 58 Lung Uninvolved lung tissue of A6,B6 Normal
C7 23 M 56 Lung Uninvolved lung tissue of A7,B7 Normal
C8 24 F 48 Lung Uninvolved lung tissue of A8,B8 Normal
D1 25 M 57 Lung Squamous cell carcinoma I T2N1M0 Malignant
D2 26 F 50 Lung Squamous cell carcinoma II T2N2M0 Malignant
D3 27 F 60 Lung Squamous cell carcinoma III T2N2M0 Malignant
D4 28 M 56 Lung Squamous cell carcinoma III T2N0M0 Malignant
D5 29 M 52 Lung Squamous cell carcinoma III T2N1M0 Malignant
D6 30 M 72 Lung Squamous cell carcinoma III T2N0M0 Malignant
D7 31 M 34 Lung Small cell lung carcinoma T2N0M0 Malignant
D8 32 M 62 Lung Small cell lung carcinoma T2N2M0 Malignant
E1 33 M 57 Lung Squamous cell carcinoma I T2N1M0 Malignant
E2 34 F 50 Lung Squamous cell carcinoma II T2N2M0 Malignant
E3 35 F 60 Lung Squamous cell carcinoma III T2N2M0 Malignant
E4 36 M 56 Lung Squamous cell carcinoma III T2N0M0 Malignant
E5 37 M 52 Lung Squamous cell carcinoma III T2N1M0 Malignant
E6 38 M 72 Lung Squamous cell carcinoma III T2N0M0 Malignant
E7 39 M 34 Lung Small cell lung carcinoma T2N0M0 Malignant
E8 40 M 62 Lung Small cell lung carcinoma T2N2M0 Malignant
F1 41 M 57 Lung Uninvolved lung tissue of D1,E1 Normal
F2 42 F 50 Lung Uninvolved lung tissue of D2,E2 Normal
F3 43 F 60 Lung Uninvolved lung tissue of D3,E3 Normal
F4 44 M 56 Lung Uninvolved lung tissue of D4,E4 Normal
F5 45 M 52 Lung Uninvolved lung tissue of D5,E5 Normal
F6 46 M 72 Lung Uninvolved lung tissue of D6,E6 Normal
F7 47 M 34 Lung Uninvolved lung tissue of D7,E7 Normal
F8 48 M 62 Lung Uninvolved lung tissue of D8,E8 Normal

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。